Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial

Peer Review reports

Original Submission
19 Sep 2023	Submitted	Original manuscript
20 Nov 2023	Reviewed	Reviewer Report - Kirsty Loudon
23 Nov 2023	Author responded	Author comments - Edward L. Snyder
Resubmission - Version 2
23 Nov 2023	Submitted	Manuscript version 2
Publishing
24 Nov 2023	Editorially accepted
11 Dec 2023	Article published	10.1186/s13063-023-07831-x

Back to article page